Last reviewed · How we verify
CZI Rare As One: Co-designing an App and Wearable Based Compass for Rare Diseases
The CZI Rare As One study is a Chan Zuckerberg Initiative funded study that aims to co-design and pilot test unique symptom tracking and transmitting apps across 5 different sub-arms that includes individuals with Long COVID, Pancreatitis, Sarcoidosis, Vasolin-Containing Protein (VCP) disease and Primary Ciliary disease (PCD). This study aims to use multimodal digital health tools to enable patients to self-monitor their symptoms in passive and active ways.
Details
| Lead sponsor | 4YouandMe |
|---|---|
| Status | COMPLETED |
| Enrolment | 239 |
| Start date | Thu Feb 06 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Jul 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Pancreatitis, Chronic
- Sarcoidosis
- VCP Disease
- Long COVID
- PCD
- Symptoms and Signs
- Wearables
Interventions
- Observational - no intervention
Countries
United States